Horse Anti-Rabies Virus IgG (Fab2), neutralizing |
|
RBV16-Fab2 |
Alpha Diagnostics |
100 ul |
EUR 534 |
Human IgG antibody Laboratories manufactures the wild-type virus neutralizing antibody reagents distributed by Genprice. The Wild-Type Virus Neutralizing Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Wild-Type products are available in stock. Specificity: Wild-Type Category: Virus Group: Neutralizing Antibody
Human Herpes virus type 6 IgG antibody (HHV6-Ab-IgG) ELISA Kit |
|
Abebio |
48T |
EUR 325 |
|
Description: Human (Homo sapiens) |
Human Herpes virus type 6 IgG antibody (HHV6-Ab-IgG) ELISA Kit |
|
Abebio |
48 Tests |
EUR 325 |
|
|
|
Description: Human (Homo sapiens) |
Human Herpes virus type 6 IgG antibody (HHV6-Ab-IgG) ELISA Kit |
|
Abebio |
96T |
EUR 610 |
|
Description: Human (Homo sapiens) |
Human Herpes virus type 6 IgG antibody (HHV6-Ab-IgG) ELISA Kit |
|
Abebio |
96 Tests |
EUR 610 |
|
|
|
Description: Human (Homo sapiens) |
Human Herpes virus type 8 IgG antibody (HHV8-Ab-IgG) ELISA Kit |
|
Abebio |
48T |
EUR 325 |
|
Description: Human (Homo sapiens) |
Human Herpes virus type 8 IgG antibody (HHV8-Ab-IgG) ELISA Kit |
|
Abebio |
48 Tests |
EUR 325 |
|
|
|
Description: Human (Homo sapiens) |
Neutralizing Antibody information
Human Immunodeficiency Virus Type 1 (Strain MN) (HIV-1, Principal Neutralizing Domain-PND) (HRP) |
|
MBS6125634-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3530 |
Human Immunodeficiency Virus Type 1 (Strain MN) (HIV-1, Principal Neutralizing Domain-PND) (PE) |
|
MBS6125867-01mL |
MyBiosource |
0.1(mL |
EUR 820 |
Human Immunodeficiency Virus Type 1 (Strain MN) (HIV-1, Principal Neutralizing Domain-PND) (PE) |
|
MBS6125867-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3530 |
Human Immunodeficiency Virus Type 1 (Strain MN) (HIV-1, Principal Neutralizing Domain-PND) (AP) |
|
MBS6124699-01mL |
MyBiosource |
0.1(mL |
EUR 820 |
Human Immunodeficiency Virus Type 1 (Strain MN) (HIV-1, Principal Neutralizing Domain-PND) (AP) |
|
MBS6124699-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3530 |
Human Immunodeficiency Virus Type 1 (Strain MN) (HIV-1, Principal Neutralizing Domain-PND) (APC) |
|
MBS6124932-01mL |
MyBiosource |
0.1(mL |
EUR 820 |
Human Immunodeficiency Virus Type 1 (Strain MN) (HIV-1, Principal Neutralizing Domain-PND) (APC) |
|
MBS6124932-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3530 |
Anti-BCMA Neutralizing Antibody, Mouse IgG1 (recommended for neutralizing assay) |
|
BCA-M43 |
ACROBIOSYSTEMS |
100ug |
EUR 2398 |
|
|
|
Description: Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) is also known as B-cell maturation protein (BCMA), CD antigen CD269, which is a member of the TNF-receptor superfamily. TNFRSF17 contains one TNFR-Cys repeat. TNFRSF17 is expressed in mature B-cells, but not in T-cells or monocytes. TNFRSF17 is receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. TNFRSF17 promotes B-cell survival and plays a role in the regulation of humoral immunity. TNFRSF17 can activate NF-kappa-B and JNK. |
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC) |
|
abx411284-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
|
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC) |
|
abx411284-100g |
Abbexa |
100 µg |
EUR 425 |
DKK-1 Neutralizing Antibody |
|
MBS8101470-02mg |
MyBiosource |
0.2mg |
EUR 280 |
DKK-1 Neutralizing Antibody |
|
MBS8101470-05mg |
MyBiosource |
0.5mg |
EUR 375 |
DKK-1 Neutralizing Antibody |
|
MBS8101470-5x05mg |
MyBiosource |
5x0.5mg |
EUR 1545 |
NGF/NGFB Neutralizing Antibody |
|
MBS8104707-02mg |
MyBiosource |
0.2mg |
EUR 280 |
NGF/NGFB Neutralizing Antibody |
|
MBS8104707-05mg |
MyBiosource |
0.5mg |
EUR 375 |
NGF/NGFB Neutralizing Antibody |
|
MBS8104707-5x05mg |
MyBiosource |
5x0.5mg |
EUR 1545 |
NGF/NGFB Neutralizing Antibody |
|
MBS8104710-02mg |
MyBiosource |
0.2mg |
EUR 280 |
